Dopamine and diltiazem-induced natriuresis in the spontaneously hypertensive rat

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 1 42-1, 1997, Pages

  Eisner, Gilbert M ^a   Asico, Laureano D ^a   Albrecht, Frederick E ^a   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine 1 receptor; Sodium pump activity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DILTIAZEM; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; EFFECTOR CELL; ENZYME ACTIVITY; GENETIC TRANSDUCTION; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; STIMULUS RESPONSE;

EID: 0030788935     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.1.r317     Document Type: Article

References (32)

1. 1A dopamine receptor in the pathogenesis of genetic hypertension. J. Clin. Invest. 97: 2283-2288, 1996.
2. +-ATPase activity in rat proximal convoluted tubule segments. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F39-F45, 1987.
3. Chatziantoniou, C., X. Ruan, and W. J. Arendshorst. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F845-F852, 1993.
4. Chen, C., R. E. Beach, and M. F. Lokhandwala. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21: 364-372, 1993.
5. Chen, C. J., and M. F. Lokhandwala. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 14: 615-628, 1992.
6. Chen, C. J., S. J. Vyas, J. Eichberg, and M. F. Lokhandwala. Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats. Hypertension 19: 102-108, 1992.
7. Cowley, A. W., R. J. Roman, F. J. Fenoy, and D. L. Mattson. Effect of renal medullary circulation on arterial pressure. J. Hypertens. 10, Suppl. 7: S193-S197, 1992.
8. Debska-Slizien, A., P. Ho, R. Drangova, and A. D. Baines. Endogenous dopamine regulates phosphate reabsorption but not Na K-ATPase in spontaneously hypertensive rat kidneys. J. Am. Soc. Nephrol. 5: 1125-1132, 1994.
9. Eisner, G. M., L. D. Asico, and P. A. Jose. Role of renal dopamine-1 receptors in the natriuresis induced by calcium channel blockers. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F965-F970, 1994.
10. Felder, C. C., A. M. McKelvey, M. S. Gitler, G. M. Eisner, and P. A. Jose. Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int. 36: 183-193, 1989.
11. Felder, R. A., S. Kinoshita, K. Ohbu, M. M. Mouradian, D. R. Sibley, F. J. Monsma, Jr., L. M. Canessa, and P. A. Jose. Renal dopamine-1 receptor mRNA and organ specificity of the dopamine-1 receptor/adenylyl cyclase coupling defect in the spontaneously hypertensive rat. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R726-R732, 1993.
12. Felder, R. A., M. G. Seikaly, P. Cody, G. M. Eisner, and P. A. Jose. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990.
13. Fenoy, F. J., M. L. Kauker, I. Milicic, and R. J. Roman. Normalization of pressure-natriuresis by nisoldipine in spontaneously hypertensive rats. Hypertension 19: 49-55, 1992.
14. Garthoff, B., C. Hirth, A. Federmann, S. Kazda, and J.-P. Stasch. Renal effects of 1,4 dihydropyridines in animal models of hypertension and renal failure. J. Cardiovasc. Pharmacol. 9, Suppl. 1: S8-S13, 1987.
15. Gebremedhim, D., F. J. Fenoy, D. R. Harder, and R. J. Roman. Enhanced vascular tone in the renal vasculature of spontaneously hypertensive rats. Hypertension 16: 648-654, 1990.
16. + exchanger in spontaneously hypertensive rats. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F526-F536, 1991.
17. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J. Clin. Invest. 95: 2083-2088, 1995.
18. Ikenaga, H., H. Suzuki, N. Ishi, H. Itoh, and T. Saruta. Role of NO on pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats. Kidney Int. 43: 205-211, 1993.
19. Jose, P. A., G. M. Eisner, J. Drago, R. M. Carey, and R. A. Felder. Dopamine receptor signaling defects in spontaneous hypertension. Am. J. Hypertens. 9: 400-405, 1996.
20. Jose, P. A., G. M. Eisner, and J. E. Robillard. Renal hemodynamics and natriuresis induced by dopamine-1 agonist, SKF 82526. Am. J. Med. Sci. 294: 181-186, 1987.
21. Kaiser, C., F. E. Ali, W. E. Bondinell, M. Brenner, K. G. Holden, T. W. Ku, H.-J. Oh, S. T. Ross, N. C. F. Yim, C. L. Zirkle, R. A. Hahn, H. M. Sarau, P. E. Setler, and J. R. Wardell, Jr. 6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-H-3-benzazepines, a novel class of dopamine receptor antagonists and neuroleptics. J. Med. Chem. 23: 975-976, 1980.
22. Kaneko, S., F. Albrecht, L. D. Asico, G. M. Eisner, J. E. Robillard, and P. A. Jose. Ontogeny of the dopamine-1 receptor mediated natriuresis in the rat: in vivo and in vitro correlations. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R631-R638, 1992.
23. Kinoshita, S., A. Sidhu, and R. A. Felder. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J. Clin. Invest. 84: 1849-1856, 1989.
24. Loutzenhiser, R., and M. Epstein. The renal hemodynamic effects of calcium antagonists. In: Calcium Antagonists and the Kidney, edited by M. Epstein and R. Loutzenhiser. Philadelphia, PA: Hanley and Belfast, 1990, p. 33-73.
25. Lupinacci, L., C. Palomino, A. Greenberg, and J. B. Puschett. Chronic effects of nitrendipine on renal hemodynamics and tubular transport. Clin. Pharmacol. Ther. 43: 6-15, 1988.
26. McKee, M., C. Scavone, and J. A. Nathanson. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc. Natl. Acad. Sci. USA 91: 12056-12060, 1994.
27. Siragy, H. M., R. A. Felder, N. L. Howell, R. L. Chevalier, M. J. Peach, and R. M. Carey. Evidence that dopamine-2 mechanisms control renal function. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F793-F800, 1990.
28. Siragy, H. M., R. A. Felder, N. L. Howell, R. L. Chevalier, M. J. Peach, and R. M. Carey. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol. 26): F469-F477, 1989.
29. +)-ATPase regulation by the sympathetic nervous system: effects of noradrenergic stimulation and lesions in vivo. J. Pharmacol. Exp. Ther. 228: 304-311, 1984.
30. 2 autoreceptors and guanosine triphosphate binding proteins. Am. J. Hypertens. 5: 642-647, 1992.
31. Vemulapalli, S., P. J. S. Chu, and E. J. Sybertz. Comparative renal effects of calcium channel blockers in conscious spontaneously hypertensive rats. Arch. Int. Pharmacodyn. 287: 309-322, 1987.
32. Yokoyama, T., Y. Masuda, T. Sakai, S. Tanaka, and K. Tomita. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 19: 851-856, 1992.